In Vitro and In Vivo Effects of Genistein on Murine Alveolar Macrophage TNFα Production
- 94 Downloads
The present study was performed to determine whether genistein could inhibit in vivo LPS-induced alveolar macrophage TNFα production and thus reduce the alveolar neutrophil influx following LPS. In vitro incubation with genistein completely inhibited LPS-induced TNFα production by alveolar macrophages (AM) from BALB/c mice. Subsequently mice were pretreated with intraperitoneal genistein or vehicle, then received nasal LPS to induce an alveolitis. Genistein was then administered every eight hours for five days following LPS. At 24 hours after LPS, the bronchoalveolar lavage (BAL) TNFα and ex vivo TNFα production from AM, were lower in the genistein treated animals. As well, total BAL white blood cell (WBC) count was reduced in the genistein as compared to the vehicle-only group. The percent neutrophils and the resolution of neutrophils were similar between genistein and vehicle groups. Therefore, genistein was able to decrease AM TNFα production, and was associated with a decrease in BAL WBC count post-LPS.
KeywordsPublic Health Internal Medicine Blood Cell White Blood Cell White Blood Cell Count
Unable to display preview. Download preview PDF.
- 1.Jausteen, B. 1983. Flavonoids: a class of natural products of high pharmacological potency. Biochem. Pharmacol. 32:1141-1148.Google Scholar
- 2.Geng, Y., B. Zhang, and M. Lotz. 1993. Protein tyrosine kinase activity is required for lipopolysaccharide induction of cytokines in human blood monocytes. J. Immunol. 151:6692-6700.Google Scholar
- 3.Alcaraz, M. J., and A. Villar. 1989. Anti-inflammatory effects of natural phenolic compounds. In: CRC Handbook of Free Radicals and Antioxidants in Biomedicine. Vol. 2, 77-85. CRC Press Boca Raton, Florida.Google Scholar
- 4.Baumann, J., F. Bruchhausen, and G. Wurm. 1980. Flavonoids and related compounds as inhibitors of arachidonic acid peroxidation. Prostaglandins 20:627-639.Google Scholar
- 5.Supko, J. G., and L. Malspeis, 1995. Plasma pharmacokinetics of genistein in mice. Int. J. Onc. 7:847-854.Google Scholar
- 6.Flick, D. A., and G. E. Gifford. 1984. Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J. Immunol. Meth. 68:167-175.Google Scholar
- 7.Morris, P. E., J. Glass, R. Cross, and D. A. Cohen. 1997. Lymphocyte subset analysis in the resolution of endotoxin-induced lung injury. Inflammation 21:269-278.Google Scholar
- 8.Lepidi, H., R. Ciubotariu, P. Bongrand, C. Capo, R. Barot-Ciorbaru, and J. L. Mege. 1994. Protein tyrosine kinases and TNFα secretion in human monocytes. Int. J. Immunopharm. 16:407-412.Google Scholar
- 9.Yoza, B. K., J. Y. Q. Hu, and C. E. McCall. 1996. Protein tyrosine kinase activation is required for lipopolysaccharide induction of interleukin 1 beta and NF-kB activation, but not NF-kB nuclear translocation. J. Biol. Chem. 271:18306-18309.Google Scholar
- 10.Novogrodsky, A., A. Vanichkin, M. Patya, A. Gazit, N. Osherov, and A. Levitzki. 1994. Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors. Science 264:1319-1322.Google Scholar
- 11.Steinberg, K., J. A. Milberg, T. R. Martin, R. F. Maunder, B. A. Cockrill, and L. D. Hudson. 1994. Evolution of broncholaveolar cell populations in the adult respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 150:113-122.Google Scholar